FYERS
Medico Remedies21.59
-0.24 (-1.10%)

Medico Remedies Share Price

21.59-0.24 (-1.10%)
-57.63% past 1 Year

Corporate filings & documents

Announcements

Please find enclosed.
1 week ago
Please find enclosed.
1 week ago
The Exchange has sought clarification from Medico Remedies Ltd on September 29 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 week ago
The Exchange has sought clarification from Medico Remedies Ltd on September 29 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 week ago
Please find enclosed Intimation for Closure of Trading Window
1 week ago
Please find enclosed Intimation for Closure of Trading Window
1 week ago
Please find enclosed Voting Results and Scrutinizer Report for AGM
2 weeks ago
Please find enclosed Voting Results and Scrutinizer Report for AGM
2 weeks ago
Please Find Enclosed Proceedings of 32nd AGM
2 weeks ago
Please Find Enclosed Proceedings of 32nd AGM
2 weeks ago
Please find enclosed.
1 month ago
Please find enclosed.
1 month ago
Please find enclosed.
1 month ago
Please find enclosed.
1 month ago
Please find enclosed.
1 month ago
Please find enclosed.
1 month ago
Please find enclosed
1 month ago
Please find enclosed
1 month ago
Please find enclosed outcome
1 month ago
Please find enclosed outcome
1 month ago
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve Unaudited Financial Results for the quarter ended 30th June 2026 along with the Limited Review Report thereon; and2. Any other business with the permission of the Chair.
1 month ago
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. To consider and approve Unaudited Financial Results for the quarter ended 30th June 2026 along with the Limited Review Report thereon; and2. Any other business with the permission of the Chair.
1 month ago
Please find enclosed
2 months ago
Please find enclosed
2 months ago
The Exchange has sought clarification from Medico Remedies Ltd on August 3 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
2 months ago
The Exchange has sought clarification from Medico Remedies Ltd on August 3 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
2 months ago
Please find enclosed
3 months ago
Please find enclosed
3 months ago
Please find enclosed
3 months ago
Please find enclosed
3 months ago
Please find enclosed
4 months ago
Please find enclosed
4 months ago
Please find enclosed
4 months ago
Please find enclosed
4 months ago
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Medico Remedies Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24230MH1994PLC077187</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2024-25 2025-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>VIDHI ANKIT SHAH</td></tr><tr><td>Designation :-</td><td>COMPANY SECRETARY AND COMPLIANCE OFFICER</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>HARESH MEHTA</td></tr> <tr><td>Designation : -</td><td>WHOLE TIME DIRECTOR AND CFO</td></tr></table><div> <br/> Date: 21/05/2026<br/><br/></div>
4 months ago
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Medico Remedies Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24230MH1994PLC077187</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2024-25 2025-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>VIDHI ANKIT SHAH</td></tr><tr><td>Designation :-</td><td>COMPANY SECRETARY AND COMPLIANCE OFFICER</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>HARESH MEHTA</td></tr> <tr><td>Designation : -</td><td>WHOLE TIME DIRECTOR AND CFO</td></tr></table><div> <br/> Date: 21/05/2026<br/><br/></div>
4 months ago
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 21st May 2026 has inter alia considered and approved the following:1. Audited Standalone Financial Results of the Company for the quarter ended 31st March 2026 and Audited Financial Statements for the year ended on 31st March 2026 along with the Auditors Report thereon.We would like to state that M/s. Shah Shroff & Associates Statutory Auditors of the Company have issued audit report with unmodified opinion on the Statements.2. Boards Report and its annexures Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March 2026.We wish to inform you that the Board Meeting commenced today at 5:00 P.M and concluded at 5:25 P.M.
4 months ago
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 21st May 2026 has inter alia considered and approved the following:1. Audited Standalone Financial Results of the Company for the quarter ended 31st March 2026 and Audited Financial Statements for the year ended on 31st March 2026 along with the Auditors Report thereon.We would like to state that M/s. Shah Shroff & Associates Statutory Auditors of the Company have issued audit report with unmodified opinion on the Statements.2. Boards Report and its annexures Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March 2026.We wish to inform you that the Board Meeting commenced today at 5:00 P.M and concluded at 5:25 P.M.
4 months ago
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve 1. Audited Financial Results for the quarter ended 31st March 2026 and Audited Financial Statements for the year ended on 31st March 2026; and2. Any other business with the permission of the Chair.
4 months ago
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve 1. Audited Financial Results for the quarter ended 31st March 2026 and Audited Financial Statements for the year ended on 31st March 2026; and2. Any other business with the permission of the Chair.
4 months ago
Please find enclosed
5 months ago
Please find enclosed
5 months ago
Please find enclosed
7 months ago
Please find enclosed
7 months ago
Please find enclosed
7 months ago
Please find enclosed
7 months ago
Please find enclosed
7 months ago
Please find attached Quarterly Financial Results for the quarter ended 31st December 2025
7 months ago
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 12th February 2026 has inter alia considered and approved the following: 1. Unaudited Standalone Financial Results for the quarter and half year ended 31st December 2025 along with Auditors Limited Review Report thereon; (enclosed)We wish to inform you that the Board Meeting commenced today at 5:00 P.M. and concluded at 05:30 P.M
7 months ago
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve 1. Unaudited Financial Results for the quarter ended 31st December 2025 along with the Limited Review Report thereon; 2. Any other business with the permission of the Chair
8 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Nov 2023
ConcallPresentation
Nov 2022
ConcallPresentation

Medico Remedies Ltd Share Price Today

The Medico Remedies Ltd share price today is ₹21.7. During the trading session, the Medico Remedies Ltd share price opened at ₹21.84 and recorded an intraday high of ₹22.49 and a low of ₹21.02. Last closing price was ₹21.53. Over the past 52 weeks, the Medico Remedies Ltd share price has ranged between ₹20.47 and ₹56.88. The current Medico Remedies Ltd stock price reflects real-time market activity based on executed trades on the exchange.